Total pancreatectomy: Short- and long-term outcomes at a high-volume pancreas center

Table 4 Pathologic findings for 103 patients undergoing total pancreatectomy

Variable	Overall (n = 103)	LTP (n = 24)
Malignant	n = 53	n = 12
Pancreatic ductal adenocarcinoma	42 (40.8%)	5 (20.8%)
De novo	23 (22.3%)	3 (12.5%)
Arising from IPMN	19 (18.5%)	2 (8.3%)
Neuroendocrine	7 (6.8%)	6 (25%)
Cholangiocarcinoma with IPMN	1 (0.97%)	0
Ampullary adenocarcinoma with IPMN	1 (0.97%)	1 (4.2%)
Renal cell carcinoma	1 (0.97%)	0
Sarcoma	1 (0.97%)	0
Tumor size, cm1	3.5 ± 2.4 (0.5%-14%)	3.2 ± 2.5 (1.3%-10%)
Margin negative (R0)	41 (77.4%)	11 (91.7%)
Number of lymph nodes harvested1	23 ± 14 (1%-61%)	28 ± 11 (11%-41%)
Non malignant	n = 50	n = 12
IPMN	40 (38.8%)	11 (45.8%)
Chronic pancreatitis	8 (7.8%)	1 (4.2%)
Ampullary adenoma with IPMN	1 (0.97%)	0
Trauma	1 (0.97%)	0

¹Values are mean (range), values in parenthesis are percentages unless otherwise indicated. IPMN: Intraductal papillary mucinous neoplasm; LTP: Laparoscopic total pancreatectomy.